Pelthos Therapeutics PTHS Estimates

NYSE PTHS
$21.50 +0.29 (+1.37%)
As of: Sep 30, 2026 · 3:55 PM EDT
Analyst Estimates

Pelthos Therapeutics Inc. Quarterly Revenue Estimates

Periods 9
Next Period Q3 26
Consensus 17.13 M

Analysts expect Pelthos Therapeutics Inc. to report revenue of 17.13 M for Q3 26, against a range of 15.51 M to 18.76 M. The most recent reported quarter, Q2 26, came in at 15.60 M, a 2.3% miss against the 15.96 M consensus.

Metric Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27
Reported (Actual) 0.007.41 M9.39 M10.91 M15.60 M----
High Estimate 0.004.53 M9.85 M11.76 M16.45 M18.76 M19.65 M22.88 M27.98 M
Low Estimate 0.003.75 M9.11 M10.02 M15.48 M15.51 M17.69 M19.61 M24.39 M
Consensus Estimate 0.004.14 M9.48 M10.89 M15.96 M17.13 M18.67 M21.25 M26.19 M
Analyst Estimates

Pelthos Therapeutics Inc. Quarterly Earnings Per Share (EPS) Estimates

Periods 12
Next Period Q2 24
Consensus -3.23

Analysts expect Pelthos Therapeutics Inc. to report earnings per share of -3.23 for Q2 24, against a range of -3.48 to -2.98. The most recent reported quarter, Q2 26, came in at -6.62, a 148.9% miss against the -2.66 consensus.

Metric Q2 24Q3 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27
Reported (Actual) ---3.21-5.38-5.30-6.87-3.09-6.62----
High Estimate -2.98-2.06-2.63-5.00-0.57-3.14-3.32-2.58-2.99-2.47-1.08-0.50
Low Estimate -3.48-2.26-2.91-5.90-0.63-3.84-3.90-2.74-3.21-2.79-1.26-0.60
Consensus Estimate -3.23-2.16-2.77-5.45-0.60-3.49-3.61-2.66-3.10-2.63-1.17-0.55

Pelthos Therapeutics Inc. Estimates API

Pull Wall Street consensus for Pelthos Therapeutics Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/estimates?ticker=PTHS&mode=revenue&api_key=YOUR_API_KEY